Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 1.00 |
| ▸ | GSK3A | P49840 | 9/20 | 1.00 |
| ▸ | TERT | O14746 | 10/20 | 0.91 |
| ▸ | AURKA | O14965 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL394120 | 0.95 | TERT (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14604056 | 0.93 | GSK3B (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14604221 | 0.88 | TERT (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL392097 | 0.88 | GSK3B (0.91) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14603718 | 0.87 | GSK3A (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14604425 | 0.87 | GSK3A (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14603849 | 0.87 | GSK3B (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14604054 | 0.86 | GSK3B (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14603984 | 0.86 | GSK3A (1.00) | GSK3BGSK3ATERTAURKA | |
| SCHEMBL14603994 | 0.85 | GSK3B (0.85) | GSK3BGSK3ATERTAURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013007663-A1 | 2-BENZYLSULFANYL[1,3,4]-OXADIAZOLE DERIVATIVES, AND MEDICAL USE THEREOF | Technische Universität Darmstadt (DE) | 2013-01-17 | — | — | WO | claimed |
| WO-2013007663-A1 | 2-BENZYLSULFANYL[1,3,4]-OXADIAZOLE DERIVATIVES, AND MEDICAL USE THEREOF | Technische Universität Darmstadt (DE) | 2013-01-17 | — | — | WO | disclosed |